Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm Prospective Open Label Pilot Study Evaluating Short-Term Safety and Efficacy of Romiplostim in Children With Inherited and Acquired Disorders of Hematopoietic Failure

NCT04478227 is registered in ClinicalTrials.gov with Anjali Sharathkumar as lead sponsor.

NCT NCT04478227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04478227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm Prospective Open Label Pilot Study Evaluating Short-Term Safety and Efficacy of Romiplostim in Children With Inherited and Acquired Disorders of Hematopoietic Failure
Lead sponsor
Anjali Sharathkumar
Phase
Phase 1
Overall status
Completed
Start date
August 18, 2020
Completion date
January 18, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia, bone marrow failure disorders, myelodysplastic syndrome(mds), refractory cytopenia of childhood, thrombocytopenia